The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2015

Filed:

Nov. 05, 2010
Applicants:

Benjamin Sullivan, San Diego, CA (US);

Tannin A. Schmidt, Calgary, CA;

David A. Sullivan, Boston, MA (US);

Inventors:

Benjamin Sullivan, San Diego, CA (US);

Tannin A. Schmidt, Calgary, CA;

David A. Sullivan, Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61K 31/568 (2006.01); A61K 31/715 (2006.01); A61K 38/13 (2006.01); A61K 38/18 (2006.01); A61K 45/06 (2006.01); A61K 31/728 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 31/568 (2013.01); A61K 31/715 (2013.01); A61K 31/728 (2013.01); A61K 38/13 (2013.01); A61K 38/17 (2013.01); A61K 38/1841 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided herein are ophthalmically acceptable pharmaceutical compositions comprising a PRG4 inducing compound in combination with PRG4 (including a lubricant fragments, homologs, or isoforms thereof), and methods of using the same. The PRG4 inducing compound in the pharmaceutical composition of the present invention upregulates PRG4 expression and localization in the ocular surface for efficient surface boundary lubrication. In some instances, pharmaceutical compositions described herein are utilized for treating ophthalmic conditions, e.g., ocular boundary deficiency and symptoms associated therewith.


Find Patent Forward Citations

Loading…